Gene · 81
Papers2,438
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,438
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Case report: Novel ACTN4 variant of uncertain significance in a pediatric case of steroid-resistant nephrotic syndrome requesting kidney transplantation. | Front Nephrol | 2024 | 39958702 | PubTator, text mining | PubMed |
| Diagnostic and prognostic value of disulfidptosis-related genes in sepsis. | Infect Med (Beijing) | 2024 | 39610785 | PubTator, text mining | PubMed |
| The FSGS protein actinin-4 interacts with NKCC2 to regulate thick ascending limb NaCl reabsorption. | Am J Physiol Renal Physiol | 2024 | 39446130 | PubTator, text mining | PubMed |
| ADAR1 Promotes Myogenic Proliferation and Differentiation of Goat Skeletal Muscle Satellite Cells. | Cells | 2024 | 39404371 | PubTator, text mining | PubMed |
| Disulfidptosis: A New Target for Parkinson's Disease and Cancer. | Curr Issues Mol Biol | 2024 | 39329952 | PubTator, text mining | PubMed |
| Characterization of ACTN4 as a novel antiviral target against SARS-CoV-2. | Signal Transduct Target Ther | 2024 | 39289355 | PubTator, text mining | PubMed |
| Functional Insights in PLS3-Mediated Osteogenic Regulation. | Cells | 2024 | 39273077 | PubTator, text mining | PubMed |
| Terpene extract from the stem of Celastrus orbiculatus inhibits actin cytoskeleton remodelling in gastric cancer cells by regulating the protein interaction between PTBP1 and ACTN4. | J Pharm Anal | 2024 | 39263353 | PubTator, text mining | PubMed |
| Discovery of Novel TULP4/ACTN4/EWSR1/ACTB::MYB and ESRRG::DNM3 Fusions Expands Molecular Landscape of Adenoid Cystic Carcinoma Beyond Fusions Between MYB/MYBL1 and NFIB Genes. | Am J Surg Pathol | 2024 | 39235305 | PubTator, text mining | PubMed |
| Live-cell imaging and CLEM reveal the existence of ACTN4-dependent ruffle-edge lamellipodia acting as a novel mode of cell migration. | Exp Cell Res | 2024 | 39222868 | PubTator, text mining | PubMed |
| CCT3/ACTN4/TFRC axis protects hepatocellular carcinoma cells from ferroptosis by inhibiting iron endocytosis. | J Exp Clin Cancer Res | 2024 | 39210442 | PubTator, text mining | PubMed |
| MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activation. | Cancer Lett | 2024 | 39197582 | PubTator, text mining | PubMed |
| KIAA1199/CEMIP knockdown attenuates cardiac remodeling post myocardial infarction by activating TSP4 pathway in mice. | Biochim Biophys Acta Mol Basis Dis | 2024 | 39173890 | PubTator, text mining | PubMed |
| ACTN4 is associated with the malignant potential of thymic epithelial tumors through the β-catenin/Slug pathway. | Cancer Sci | 2024 | 39166351 | PubTator, text mining | PubMed |
| Disulfidptosis-related gene expression reflects the prognosis of drug-resistant cancer patients and inhibition of MYH9 reverses sorafenib resistance. | Transl Oncol | 2024 | 39146597 | PubTator, text mining | PubMed |
| The Immunosuppressive Drug LF15-0195 Acts Also on Glomerular Lesions, by a Change in Cytoskeleton Distribution in Podocyte. | Am J Nephrol | 2024 | 39074452 | PubTator, text mining | PubMed |
| Identification of key genes involved in collagen hydrogel-induced chondrogenic differentiation of mesenchymal stem cells through transcriptome analysis: the role of m6A modification. | J Mater Sci Mater Med | 2024 | 39073623 | PubTator, text mining | PubMed |
| Integrative Omics Uncovers Low Tumorous Magnesium Content as A Driver Factor of Colorectal Cancer. | Genomics Proteomics Bioinformatics | 2024 | 39052867 | PubTator, text mining | PubMed |
| Association of ACTN4 Gene Mutation with Primary Nephrotic Syndrome in Children in Guangxi Autonomous Region, China. | Genet Test Mol Biomarkers | 2024 | 38949978 | PubTator, text mining | PubMed |
| URINARY EXCRETION OF ALPHA-ACTININ-4 AND TIGHT JUNCTION PROTEIN 1 IN PATIENTS WITH TYPE 2 DIABETES AND DIFFERENT PATTERNS OF CHRONIC KIDNEY DISEASE. | Georgian Med News | 2024 | 38807395 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/81/papers?page=5